Copyright
©The Author(s) 2022.
World J Crit Care Med. Mar 9, 2022; 11(2): 92-101
Published online Mar 9, 2022. doi: 10.5492/wjccm.v11.i2.92
Published online Mar 9, 2022. doi: 10.5492/wjccm.v11.i2.92
Characteristics | Regression coefficients | Standard error | χ2 (wald) | P value | Odds ratio | 95%CI |
Intercept | -0.45044 | 0.332171 | 1.838826 | 0.175089 | 0.637351 | |
Aspirin | -1.00047 | 0.46281 | 4.67307 | 0.030639 | 0.367707 | 0.365575-2.269164 |
Warfarin | 0.382791 | 0.733339 | 0.272467 | 0.601681 | 1.466372 | 0.179321-3.701697 |
NOAC’s | -0.15984 | 0.616872 | 0.067143 | 0.795543 | 0.852277 | 0.22984-2.520831 |
P2Y12 inhibitors | 1.098044 | 0.908435 | 1.461005 | 0.22677 | 2.998296 | 0.142169-5.14458 |
HTN | 0.213851 | 0.424561 | 0.253712 | 0.614473 | 1.238438 | 0.259028-1.790559 |
DM | 0.018183 | 0.432623 | 0.001767 | 0.966474 | 1.01835 | 0.187667-1.05208 |
- Citation: Gogtay M, Singh Y, Bullappa A, Scott J. Retrospective analysis of aspirin's role in the severity of COVID-19 pneumonia. World J Crit Care Med 2022; 11(2): 92-101
- URL: https://www.wjgnet.com/2220-3141/full/v11/i2/92.htm
- DOI: https://dx.doi.org/10.5492/wjccm.v11.i2.92